Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839838 · ClinicalTrials.gov registry record · Phase 1
APBI Proton Feasibility and Phase II Study
A Phase 1 study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01839838 is a Phase 1 study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 40 participants.
The verdict
NCT01839838, a Phase 1 study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The overall objectives of the study are to establish feasibility and acute side effects of accelerated partial breast irradiation therapy, along with more long-term side effects and clinical efficacy of treatment.
Interventions
- RADIATION Proton Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-04-22 |
| Est. Completion | 2022-12-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01839838
The ClinicalTrials.gov registry entry for NCT01839838 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Therapy is the first listed.
NCT01839838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01839838 about?
NCT01839838 is a clinical study titled "APBI Proton Feasibility and Phase II Study". The overall objectives of the study are to establish feasibility and acute side effects of accelerated partial breast irradiation therapy, along with more long-term side effects and clinical efficacy of treatment.
What is the current status of trial NCT01839838?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2013-04-22. Estimated completion is 2022-12-23.
What interventions are being tested in trial NCT01839838?
The interventions under investigation include: Proton Therapy (RADIATION).
Who is sponsoring clinical trial NCT01839838?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.